Indicator Explainer
Glucose
A simple sugar monosaccharide having two isoforms, alpha and beta, with a chemical structure of C6H12O6 that acts as an energy source for both plants and animals by reacting with oxygen, generating carbon dioxide and water, and releasing energy.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C2831. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-18. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — Glucose (C2831)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C2831. NCI definition, reproduced without modification under CC BY 4.0.
- MicroRNA-26a-5p inhibits high glucose-induced Müller cells apoptosis by mediating PTEN/PI3K/Akt pathway. — Int J Ophthalmol, 2026-10-18 (PMID 42761654; literature)
- Interface-Programmed Growth of High-Aspect-Ratio 1D Ni-MOF Nanofibers on MXene for Wearable Enzyme-Free Glucose Sensing. — ACS Appl Mater Interfaces, 2026-10-12 (PMID 42854180; literature)
- Association between triglyceride-glucose indices and incident glaucoma: integrated UK Biobank and Mendelian randomization study. — Eye Vis (Lond), 2026-10-10 (PMID 42855704; literature)
- Correction to "Canagliflozin: Pharmacokinetics, tolerability and glucose/insulin effects of supratherapeutic doses in healthy horses" [Vet. J. 313 (2025) 106412]. — Vet J, 2026-10-09 (PMID 42855386; literature)
- Reduced pancreatic responsiveness to glucose plus amino acids and incretins in early versus late lactation dairy cows. — J Dairy Sci, 2026-10-09 (PMID 42855052; literature)
- SGLT2 inhibitor use is associated with reduced myocardial glucose uptake during oncologic FDG PET/CT. — J Nucl Cardiol, 2026-10-09 (PMID 42854950; literature)
- Impact of Early Versus Publicly Funded Adoption of Flash Glucose Monitoring on Metabolic Outcomes and Self-Care in Type 1 Diabetes. — J Dr Nurs Pract, 2026-10-15 (PMID 42880880; literature)
- Guidance for continuous glucose monitor (CGM) use in Canadian hospitals. — Can J Diabetes, 2026-10-15 (PMID 42880406; literature)
- Ultraflexible Multimodal Sensors with Stable Physical Sensing and Disposable Electrochemical Calibration for Long-Term Glucose Prediction. — ACS Sens, 2026-10-23 (PMID 42913465; literature)
- Beyond sleep duration: nighttime glucose in gestational diabetes mellitus. — Sleep, 2026-10-23 (PMID 42912698; literature)
- Weight, blood glucose and lipid changes in the course of long-acting cabotegravir + rilpivirine: A prospective two-year evaluation. — HIV Med, 2026-10-28 (PMID 42952023; literature)
- Estimated glucose disposal rate and mortality in patients with cardiovascular disease: findings from two large cohorts. — Open Heart, 2026-10-28 (PMID 42951308; literature)